Mylan NV (USD)
MYL
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range17.00 | 17.83
52-Wk Range- | -
Last Close17.07
Mkt Cap (m)8,824.24
Dividend yield-
ISINNL0011031208
Volume6,108,480.00
Exchange VenueNAS

Company Profile

Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.

Key Information
Price/Earning142.25
Price/Book0.78
Price/Sales0.76
P/CF4.13
Rev Growth (3 year avg)1.26
EPS Growth (3 year avg)-0.68
Operating Margin % 6.04
Net Margin %0.15
Return on Equity0.14
Debt/Equity1.01

Documents

Prospectus
en 11/12/2018
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)7,719.609,429.3011,076.9011,907.7011,433.9011,500.50
Operating Income (m)1,400.501,363.501,374.101,424.00856.10694.10
Net Income (m)929.40847.60480.00696.00352.5016.80
Basic EPS2.491.800.941.300.690.03
Avg. Diluted Shares Outstanding (m)398.00497.40520.50536.70516.50516.50
Balance Sheet
USD201420152016201720182019
Current Assets (m)6,786.906,472.707,522.507,213.306,367.706,757.30
Non Current Assets (m)9,099.7015,795.0027,203.7028,593.0026,367.2024,498.20
Total Assets (m)15,886.6022,267.7034,726.2035,806.3032,734.9031,255.50
Current Liabilities (m)5,305.704,122.205,040.706,385.304,587.805,569.10
Total Liabilities (m)------
Total Equity (m)3,255.909,764.4011,116.2013,307.6012,167.1011,883.80
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)1,014.802,008.502,047.202,064.802,341.701,803.70
Capital Expenditure (m)-754.40-871.70-750.60-896.20-1,195.60-406.00
Figures are quoted in USD unless stated otherwise
0.55 (3.22%)
$
17.62
Last Price